Katherine Anderson Net Worth & Insider Trades
Katherine Anderson - CHIEF FINANCIAL OFFICER, Repros Therapeutics Inc
What is Katherine Anderson's Net Worth?
The current estimated net worth of Repros Therapeutics Inc's CHIEF FINANCIAL OFFICER, Katherine Anderson, is estimated to be about $721.26K . Katherine Anderson owns about 23,875 units of Repros Therapeutics Inc common stock. In the last 3 years at Repros Therapeutics Inc, Katherine Anderson has sold an estimated value of $56.2K worth.
What is Katherine Anderson's Past Insider Trading?
Katherine Anderson's largest purchase order was 12,000 units , worth over $12.96K on January 28, 2016. In total, Katherine Anderson has made about 9 transactions over 3 years of their time at Repros Therapeutics Inc. Katherine Anderson usually trades in January and February, with the busiest year in 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Katherine Anderson
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Katherine Anderson's' Mailing Address?
- Mailing address is 2408 Timberloch Place, B-7 The Woodlands TX 77380 TX
Repros Therapeutics Inc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|
| Pablo Legorreta Pablo Legorreta | 2020 | $55,674,558 | $55,674,558 | $55,674,558 | $55,674,558 |
| Pablo Legorreta Pablo Legorreta | 2019 | $28,545,792 | $28,545,792 | $28,545,792 | $28,545,792 |
| Terrance Coyne Terrance Coyne | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| Terrance Coyne Terrance Coyne | 2019 | $1,925,625 | $1,925,625 | - | $1,925,625 |
| Christopher Hite | 2020 | $3,644,711 | $3,644,711 | $367,788 | $3,644,711 |
| Christopher Hite | 2019 | - | - | - | - |
| George Lloyd George Lloyd | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| George Lloyd George Lloyd | 2019 | $2,182,500 | $2,182,500 | - | $2,182,500 |
| James Reddoch, Ph.D. James Reddoch, Ph.D. | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| James Reddoch, Ph.D. James Reddoch, Ph.D. | 2019 | $2,082,500 | $2,082,500 | - | $2,082,500 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm
What are Repros Therapeutics Inc's Past Insider Trades?
Repros Therapeutics Inc's most recent insider trade came on August 11, 2023 by Terrance P Coyne who sold 75,000 units worth $2.31M . In the last 7 years, insiders at Repros Therapeutics Inc have sold an estimated value of $809.94M and bought an estimated value of $165.99M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are George W Lloyd, EVP, Rory B Riggs, Director, and Henry A Fernandez, Director .
REPROS THERAPEUTICS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||